Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-03

Clinical Trial Update: A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase III trial of BMS-188667 in active rheumatoid arthritis completed with results posted in May 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BMS-188667

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2011-05-03